New developments reveal a molecule with a promising function in terms of cancer treatment.
Researchers from Inserm and CNRS from the Institute for genetics and molecular and cellular biology (IGBMC) and from the Research Institute at the Strasbourg school of biotechnology (Irebs) have focussed their efforts on ...
Cancer
Oct 30, 2012 |
5 / 5 (1) |
0
|
Biomarkers of behavior, therapeutic targets for adult B-acute lymphoblastic leukemia identified
New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.
Cancer
Oct 29, 2012 |
not rated yet |
0
|
Scientists identify progenitor cells, potential new 'roots' of breast cancer
Scientists have discovered new types of early cells in mammary glands, uncovering clues to the origins of different breast cancers - and potential new drug targets, according to findings published in Breast Ca ...
Cancer
Oct 29, 2012 |
2 / 5 (1) |
0
|
Study finds diabetes raises levels of proteins linked to Alzheimer's features
Growing evidence suggests that there may be a link between diabetes and Alzheimer's disease, but the physiological mechanisms by which diabetes impacts brain function and cognition are not fully understood. ...
Alzheimer's disease & dementia
Oct 26, 2012 |
5 / 5 (1) |
0
|
New target for treating diabetic kidney disease, the leading cause of kidney failure
Researchers have discovered a new therapeutic target for diabetic nephropathy, the leading cause of kidney failure. The findings, appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) ...
Diseases, Conditions, Syndromes
Oct 18, 2012 |
5 / 5 (1) |
0
Researchers elucidate transport pathway of immune system substances
To transport substances from the site of their production to their destination, the body needs a sophisticated transport and sorting system. Various receptors in and on the cells recognize certain molecules, pack them and ...
Immunology
Oct 18, 2012 |
not rated yet |
0
|
Some MS patients experience 'natural' improvements in disability
(Medical Xpress)—Multiple sclerosis (MS) patients sometimes experience "natural" improvements in disability at least over the short term, according to a new study led by researchers at the University of British Columbia ...
Neuroscience
Oct 18, 2012 |
3 / 5 (1) |
0
|
An epigenetic difference in twins explains different risk of breast cancer
Monozygotic twins have the same genome, that is, the same DNA molecule in both siblings. Despite being genetically identical, both twins may have different diseases at different times. This phenomenon is ...
Cancer
Oct 17, 2012 |
not rated yet |
0
Cold viruses point the way to new cancer therapies
Cold viruses generally get a bad rap—which they've certainly earned—but new findings by a team of scientists at the Salk Institute for Biological Studies suggest that these viruses might also be a valuable ...
Cancer
Oct 16, 2012 |
5 / 5 (5) |
0
|
Study shows fit elderly patients should be considered for therapy
Until there are more validated biomarkers to direct treatment decisions, many physicians use patient age to decide what therapy to give their patients. Literature data report that older patients often go undertreated because ...
Cancer
Oct 15, 2012 |
not rated yet |
0
Traumatic injury research working to improve the lives of citizens and soldiers
New studies presented today offer vivid examples of how advances in basic brain research help reduce the trauma and suffering of innocent landmine victims, amateur and professional athletes, and members of the military. The ...
Neuroscience
Oct 15, 2012 |
not rated yet |
0
Finding the origins of infant leukaemia
Leukaemia arises as a result of genetic or epigenetic alterations in blood cells, leading to an aberrant accumulation of undifferentiated blasts. Understanding the molecular pathogenesis and aetiology of ...
Cancer
Oct 15, 2012 |
5 / 5 (1) |
0
New study to combat the most common form of liver cancer
Scientists at the University of Southampton are to investigate the best way to use natural killer cells (NK) to target the most common form of liver cancer.
Cancer
Oct 12, 2012 |
not rated yet |
0
First WGS of multiple pancreatic cancer patients outlined in new study
Whole genome sequencing—spelling out all 3 billion letters in the human genome—"is an obvious and powerful method for advancing our understanding of pancreatic cancer," according to a new study from TGen, Mayo Clinic ...
Cancer
Oct 10, 2012 |
not rated yet |
0
|
Loss of protective heart failure protein linked to critical limb ischemia
Restoring diminished levels of a protein shown to prevent and reverse heart failure damage could also have therapeutic applications for patients with critical limb ischemia (CLI), suggests a new preclinical study published ...
Medical research
Oct 10, 2012 |
not rated yet |
0
|
